Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
A renowned company best known for its brain implants has made headway towards more applications for its latest design, with Synchron announcing its milestones for the Stentrode device. The company ...
NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
Synchron has reported that its miniature brain-computer interface implant, threaded up through the blood vessels to help read the activity of the motor cortex, showed no major side effects in a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Interim results from the COMMAND study evaluating the ...
Synchron has developed a minimally invasive brain-computer interface capable of controlling devices like Apple Vision Pro, and it has reached the one-year milestone without serious adverse effects to ...
Mark Jackson, who lives with ALS, received Synchron's Stentrode system brain-computer interface (BCI) implant in August 2023. In the video, Jackson says that he wants to use whatever time he has left ...
As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer Interfaces and Neuromodulation.
Neurotech company Synchron has been making massive strides over the past couple of years. It's just announced that a trial participant has used its brain-computer interface (BCI) to turn on the lights ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback